Literature DB >> 17037116

Field testing the WHOQOL-100 in Canada.

Anita E Molzahn1, Ginette Pagé.   

Abstract

The purpose of this project was to test the WHOQOL-100, an instrument for assessing quality of life (QOL), developed to facilitate cross-cultural comparison. The instrument was tested with a convenience sample of 144 people. The mean age of participants was 58 years and 41% were female.Test-retest reliability was .86 for the physical domain, .78 for the psychological domain, .91 for independence, .87 for social relationships, .77 for environment, and .60 for spirituality. Consistency reliability was .77 for physical, .79 for psychological, .89 for independence, .71 for social relationships, .80 for environment, and .89 for spirituality/ personal beliefs. Correlations of the various domains with other instruments, including the SF-36, the Self-Anchoring Striving Scale, and the Visual Analogue Scale for Pain, supported the convergent validity of the instrument. The instrument was able to discriminate between healthy and ill populations, providing support for construct validity.

Entities:  

Mesh:

Year:  2006        PMID: 17037116

Source DB:  PubMed          Journal:  Can J Nurs Res        ISSN: 0844-5621


  3 in total

Review 1.  Screening for sexual dysfunction in women diagnosed with breast cancer: systematic review and recommendations.

Authors:  Iris Bartula; Kerry A Sherman
Journal:  Breast Cancer Res Treat       Date:  2013-09-08       Impact factor: 4.872

2.  Quality of life in mentally ill, physically ill and healthy individuals: the validation of the Greek version of the World Health Organization Quality of Life (WHOQOL-100) questionnaire.

Authors:  Maria Ginieri-Coccossis; Eugenia Triantafillou; Vlasis Tomaras; Ioannis A Liappas; George N Christodoulou; George N Papadimitriou
Journal:  Ann Gen Psychiatry       Date:  2009-10-13       Impact factor: 3.455

3.  Further validation of the Health Scale of Traditional Chinese Medicine (HSTCM).

Authors:  Darong Wu; Shilong Lai; Luojing Zhou; Xinfeng Guo; Weixiong Liang; Zehuai Wen; Aihua Ou; Guangqing Zhang; Keji Chen
Journal:  Chin Med       Date:  2009-04-30       Impact factor: 5.455

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.